2017 - 2022 (Research in equity and health)
Results 1 - 2 of 2
Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (ACCESS 2) . . .
18 Apr 2022
A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmo . . .
20 May 2022
©2022 HERDIN PLUS. All rights reserved. |
Keep up to date